# Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer

> **NCT00176241** · PHASE1 · TERMINATED · sponsor: **Susanne Arnold** · enrollment: 7 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** gemcitabine
- **DRUG:** paclitaxel
- **RADIATION:** radiation

## Key facts

- **NCT ID:** NCT00176241
- **Lead sponsor:** Susanne Arnold
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-12
- **Primary completion:** 2008-09
- **Final completion:** 2008-11
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2015-06-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00176241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00176241, "Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00176241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*